Skip to main content

Skyline Builders Group Holding Ltd. Announces Closing of $31.59 Million Private Placement

Hong Kong, Feb. 13, 2026 (GLOBE NEWSWIRE) — Skyline Builders Group Holding Limited (NASDAQ: SKBL) (the “Company”), a civil engineering services provider in Hong Kong, today announced that on February 13, 2026 (the “Closing Date”) it closed its previously announced concurrent private placements (the “Private Placements”) of its Series B Preferred Shares, par value $0.00001 per share, (the “Preferred Shares”). The Company issued an aggregate of 6,322 Preferred Shares for aggregate gross proceeds of approximately $31.59 million, before deducting placement agent fees and other offering expenses payable by the Company. Approximately $26.59 million of Preferred Shares were issued under a Regulation D offering to “accredited” investors and approximately $5 million of Preferred Shares were issued under a Regulation S offering outside of...

Continue reading

Middlesex Water Company to Report 2025 Earnings on February 19

ISELIN, N.J., Feb. 13, 2026 (GLOBE NEWSWIRE) — Middlesex Water Company (NASDAQ: MSEX) plans to report its 2025 fourth quarter and year-end financial results after the market closes on Thursday, February 19, 2026. The press release and the company’s 2025 Form 10-K filing will be available in the Investors section of the company’s website. About Middlesex Water CompanyMiddlesex Water Company (“Middlesex”) is one of the nation’s premier investor-owned water and wastewater utilities. Established in 1897, Middlesex is a trusted provider of life-sustaining services to more than half a million people in New Jersey and Delaware. The company focuses on employee engagement, operational excellence, superior customer experience, investment in infrastructure, and selective and sustainable growth to deliver value to our customers, investors,...

Continue reading

VERSES AI Inc. Will Hold a Company Overview and Update

VANCOUVER, British Columbia, Feb. 13, 2026 (GLOBE NEWSWIRE) — VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) (“VERSES” or the “Company”), a cognitive computing company specializing in next-generation agentic software systems, announces a corporate update webinar for investors. On Wednesday, February 18th at 10am PST / 1pm EST, VERSES Interim CEO David T. Scott, President & COO James Hendrickson and CFO James Christodoulou will provide a corporate overview and update. Register for the webinar at: https://verses.wistia.com/live/events/wohm9p3wx3 About VERSESVERSES is a cognitive computing company building next-generation agentic software systems modeled after the wisdom and genius of Nature. Designed around first principles found in science, physics and biology, our flagship product, Genius™, is an agentic enterprise intelligence...

Continue reading

Peyto Exploration & Development Corp. Confirms Monthly Dividend for March 13, 2026

CALGARY, Alberta, Feb. 13, 2026 (GLOBE NEWSWIRE) — Peyto Exploration & Development Corp. (TSX: PEY) (“Peyto”) confirms that the monthly dividend with respect to February 2026 of $0.11 per common share is to be paid on March 13, 2026, for shareholders of record on February 28, 2026. Dividends paid by Peyto to Canadian residents are eligible dividends for Canadian income tax purposes. Shareholders and interested investors are encouraged to visit the Peyto website at www.peyto.com to learn more about what makes Peyto one of North America’s most exciting energy companies. The website also includes a monthly report, which discusses various topics chosen by the President and CEO and includes estimates of monthly capital expenditures and production. For further information please contact: Jean-Paul LachancePresident and...

Continue reading

Refined Energy Corp. Closes C$1,500,000 Charity Flow-Through Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 13, 2026 (GLOBE NEWSWIRE) — Refined Energy Corp. (CSE: RUU | OTC: RRUUF | FRA: CWA0) (“Refined” or the “Company“) is pleased to announce that it has closed the previously announced non-brokered “charity flow-through” private placement (the “CFT Private Placement”) of units in the capital of the Company (“Units”). Pursuant to the CFT Private Placement, the Company issued 1,428,572 Units at a price of C$1.05 per Unit for gross proceeds of C$1,500,000.60. Each Unit consists of one “flow-through” common share in the capital of the Company (a “FT Share”) and one common share purchase warrant (“Warrant”), with each Warrant entitling the holder thereof to purchase one common share in the...

Continue reading

Lavoro Announces Voluntary Delisting from the Nasdaq Global Market

SÃO PAULO, Brazil, Feb. 13, 2026 (GLOBE NEWSWIRE) — Lavoro Limited (Nasdaq: LVRO, LVROW) (the “Company” or “Lavoro”) announced today that it has notified the Nasdaq Stock Market LLC (“Nasdaq”) of its decision to voluntarily delist its ordinary shares, par value $0.001 per share (the “Ordinary Shares”) and its warrants exercisable for one Ordinary Share at an exercise price of $11.50 (the “Warrants”) from the Nasdaq Global Market. Lavoro intends to file a Form 25 (Notification of Removal of Listing) with the SEC to remove its Ordinary Shares and Warrants from listing on the Nasdaq Global Market on or about February 24, 2026 and deregister such securities under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and as a result, Lavoro expects that the last trading day of its Ordinary Shares and...

Continue reading

Ocular Therapeutix™ to Announce Topline Data for SOL-1 Phase 3 Superiority Trial in Wet AMD on Tuesday, February 17, 2026

Ocular to host webcast scheduled for Tuesday, February 17, 2026, at 8:00 AM ET Detailed SOL-1 data to be presented at the 49th Macula Society Annual Meeting BEDFORD, Mass., Feb. 13, 2026 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that the Company will host a webcast to review the topline results of the SOL-1 Phase 3 superiority clinical trial of AXPAXLI™ (also known as OTX-TKI), for the treatment of wet age-related macular degeneration (wet AMD), on Tuesday, February 17, 2026. Detailed data will be presented at the 49th Macula Society Annual Meeting between February 25 – 28, 2026. Click here to register for the virtual webcast, which will begin at 8:00 AM ET. The live and archived webcast can...

Continue reading

A.I.S. Resources Announces Adoption of Shareholder Rights Plan

VANCOUVER, B.C., Feb. 13, 2026 (GLOBE NEWSWIRE) — A.I.S. Resources Limited (TSXV: AIS, OTC-Pink: AISSF) (“AIS” or the “Company”) is pleased to announce that its board of directors (the “Board”) has approved a shareholder rights plan (the “Rights Plan”). The adoption of the Rights Plan is intended to ensure, to the extent possible, that all shareholders of the Company are treated fairly in connection with any take-over bid for the Company’s shares (as defined in the Rights Plan) and to protect against acquisitions of control of the Company through purchases of shares that are exempt from applicable Canadian take-over bid rules, also referred to as “creeping” take-over bids. The Rights Plan is substantially similar to shareholder rights plans adopted by other Canadian issuers, and it was not adopted in response...

Continue reading

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Nasdaq Minimum Bid Price Requirement

DUBLIN, Feb. 13, 2026 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, received notice on February 11, 2026 from the Nasdaq Stock Market LLC (“Nasdaq”) that the Company is not in compliance with Nasdaq Listing Rule 5450(a)(1), requiring that listed securities maintain a minimum bid price of $1.00 per share, based on the closing bid price of the Company’s American Depositary Shares (“ADSs”) for the last 30 consecutive business days. This notice has no immediate effect on the listing of the Company’s ADSs, which will continue to trade at this time on the Nasdaq Global Select Market under the symbol “TRIB.” In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has a period of 180...

Continue reading

South Bow Shares Findings of Root Cause Analysis of Milepost 171 Incident

CALGARY, Alberta, Feb. 13, 2026 (GLOBE NEWSWIRE) — South Bow Corp. (TSX & NYSE: SOBO) (South Bow or the Company) and the Pipeline and Hazardous Materials Safety Administration (PHMSA) have received the independent third-party root cause analysis (RCA) of the incident that occurred at Milepost 171 (MP-171) of the Keystone Pipeline on April 8, 2025, near Fort Ransom, N.D. Root cause analysis findings According to the RCA, the characteristics of the MP-171 incident were unique. Both the pipe and welds conformed to industry standards for design, materials, and mechanical properties. Additionally, the pipe was transported in accordance with industry standards, and the pipeline was operating within its design pressure at the time of the incident. The RCA identified:The failure resulted from a fatigue crack that originated along...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.